Moderna’s COVID-19 vaccine may pose a higher risk of heart disease in some age groups than the Pfizer-BioNTech vaccine, the Centers for Disease Control and Prevention (CDC) said today, citing recent data.
The agency said, however, that the findings for myocarditis and pericarditis, an inflammation of the heart associated with both mRNA vaccines, were not consistent with all vaccine safety monitoring systems in the United States.
The CDC analysis comes as advisers to the US FDA meet today to discuss the approval of the Moderna vaccine for children and adolescents aged 6-17.
In the Vaccine Safety Datalink (VSD) database, the heart rate is 97.3 cases per million doses for men aged 18-39 after a second dose of Moderna vaccine, compared with 81.7 cases per million doses of the Pfizer vaccine.
Available information indicates that most people with myocarditis recover gradually after being vaccinated with a COVID-19 mRNA vaccine, the CDC reported.
SOURCE: ΑΠΕ-ΜΠΕ
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
